The application of immunocytochemistry to direct smears in the diagnosis of effusions

Diagnostic Cytopathology

Volumn 41, Issue 5, 2013, Pages 425-430

  Knoepp, Stewart M ^a   Placido, Jeremiah ^a   Fields, Kristina L ^a   Thomas, Dafydd ^a   Roh, Michael H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

carcinoma; cytology; direct smear; effusion; immunocytochemistry

Indexed keywords

BIOLOGICAL MARKER; CALRETININ; EMAKALIM; PROTEIN P63;

ARTICLE; EFFUSION; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MESOTHELIOMA; MESOTHELIUM CELL; METASTASIS; MICROBIOLOGICAL EXAMINATION; PANCREAS CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA; THYROID CARCINOMA; TRANSITIONAL CELL CARCINOMA;

ADENOCARCINOMA; CYTODIAGNOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; PLEURAL EFFUSION, MALIGNANT; TUMOR MARKERS, BIOLOGICAL;

EID: 84876490453     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.22852     Document Type: Article

References (28)

1. Pereira TC, Saad RS, Liu Y, Silverman JF,. The diagnosis of malignancy in effusion cytology: A pattern recognition approach. Adv Anat Pathol 2006; 13: 174-184.
2. Monte SA, Ehya H, Lang WR,. Positive effusion cytology as the initial presentation of malignancy. Acta Cytol 1987; 31: 448-452.
3. Murphy WM, Ng AB,. Determination of primary site by examination of cancer cells in body fluids. Am J Clin Pathol 1972; 58: 479-488.
4. Mulvahy N,. Cytohistologic correlation in malignant peritoneal washings. Analysis of 75 malignant fluids. Acta Cytol 1996; 40: 1231-1239.
5. Betz BL, Roh MH, Weigelin HC, et al. The application of molecular diagnostic studies interrogating EGFR and KRAS mutations to stained cytologic smears of lung carcinoma. Am J Clin Pathol 2011; 136: 564-571.
6. Swati I, Zhang S, Tull J, Khurana KK,. Accuracy of cytology specimen and needle core biopsies for detection of KRAS mutation in non-small cell carcinoma: Comparison with resection specimen. World J Oncol 2011; 2: 275-280.
7. Roh MH, Schmidt L, Placido J, et al. The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma. Diagn Cytopathol 2011 (in press).
8. Hookim K, Roh MH, Willman J, et al. Application of immunocytochemistry and BRAF mutational analysis to direct smears of metastatic melanoma. Cancer Cytopathol 2012; 120: 52-61.
9. Knoepp SM, Hookim K, Placido J, Fields KL, Roh MH,. The application of immunocytochemistry to cytologic direct smears of metastatic Merkel cell carcinoma. Diagn Cytopathol (in press).
10. Pomjanski N, Grote HJ, Doganay P, Schmiemann V, Buckstegge B, Bocking A,. Immunocytochemical identification of carcinomas of unknown primary in serous effusions. Diagn Cytopathol 2005; 33: 309-315.
11. Sato A, Torii I, Okamura Y, et al. Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium. Mod Pathol 2010; 23: 1458-1466.
12. Ueda J, Iwata T, Ono M, Takahashi M,. Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion. Diagn Cytopathol 2006; 34: 6-10.
13. Ikeda K, Tate G, Suzuki T, Kitamura T, Mitsuya T,. Diagnostic usefulness of EMA, IMP3, and GLUT-1 for the immunocytochemical distinction of malignant cells from reactive mesothelial cells in effusion cytology using cytospin preparations. Diagn Cytopathol 2011; 39: 395-401.
14. Kundu UR, Krishnamurthy S,. Use of the monoclonal antibody MOC-31 as an immunomarker for detecting metastatic adenocarcinoma in effusion cytology. Cancer Cytopathol 2011; 119: 272-278.
15. Morgan RL, De Young BR, McGaughy VR, Niemann TH,. MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells. Cancer 1999; 87: 390-394.
16. Shen J, Pinkus GS, Deshpande V, Cibas ES,. Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids. Am J Clin Pathol 2009; 131: 516-523.
17. Shield PW, Koivurinne K,. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions. Cytopathology 2008; 19: 218-223.
18. Su XY, Li GD, Liu WP, Xie B, Jiang YH,. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry. Diagn Cytopathol 2011; 39: 900-908.
19. Hasteh F, Lin GY, Weidner N, Michael CW,. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol 2010; 118: 90-96.
20. Dejmek A, Naucler P, Smedjeback A, et al. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions. Diagn Cytopathol 2007; 35: 493-497.
21. Kim JH, Kim YS, Choi YD, Lee JS, Park CS,. Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion. Acta Cytol 2011; 55: 266-270.
22. McKnight R, Cohen C, Siddiqui MT,. Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: An immunohistochemical study of metastatic ovarian serous carcinoma. Cancer Cytopathol 2010; 118: 298-302.
23. Tong GX, Devaraj K, Hamele-Bena D, et al. Pax8: A marker for carcinoma of Mullerian origin in serous effusions. Diagn Cytopathol 2011; 39: 567-574.
24. Wiseman W, Michael CW, Roh MH,. Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Mullerian carcinoma in effusions. Diagn Cytopathol 2011; 39: 651-656.
25. Bishop JA, Sharma R, Westra WH,. PAX8 immunostaining of anaplastic thyroid carcinoma: A reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck. Hum Pathol 2011; 42: 1873-1877.
26. Nonaka D, Tang Y, Chiriboga L, Rivera M, Ghossein R,. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol 2008; 21: 192-200.
27. Buza N, Cohen PJ, Pei H, Parkash V,. Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder. Int J Surg Pathol 2010; 18: 94-102.
28. Kim JH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C,. Utility of thyroid transcription factor-1 and CDX-2 in determining the primary site of metastatic adenocarcinomas in serous effusions. Acta Cytol 2010; 54: 277-282.